diazoxide


Also found in: Thesaurus, Medical, Wikipedia.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.diazoxide - vasodilator (trade name Hyperstat) used to treat severe hypertension
Hyperstat
vasodilative, vasodilator - a drug that causes dilation of blood vessels
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Mentioned in ?
References in periodicals archive ?
'We are pleased with the progress in our ongoing Phase III clinical trial, DESTINY PWS, evaluating once-daily Diazoxide Choline Controlled-Release (DCCR) tablets for patients with Prader Willi Syndrome (PWS).
Soleno Therapeutics Provides Corporate Update and Reports Second Quarter 2019 Financial Results
Soleno Therapeutics provided an update on the Company's ongoing Phase III trial, DESTINY PWS, evaluating once-daily Diazoxide Choline Controlled-Release tablets for patients with Prader-Willi Syndrome/ As of July 24, 2019, approximately 50% of the targeted number of patients have been enrolled into the DESTINY PWS clinical study and more than 90% of those patients have either successfully completed or continue to be treated on study.
Soleno initiating open-label study for patients who complete C602 study
The potentiated effect of obestatin was believed to be lost in presence of diazoxide which activated the ATP sensitive K + channels reflecting their sensitivity of these channels to obestatin12.
EFFECT OF OBESTATIN SUPPLEMENTATION ON PLASMA GLUCOSE, SERUM INSULIN AND INSULIN RESISTANCE IN HIGH FAT DIET INDUCED OBESE SPRAGUE DAWLEY RATS
She had been treated by diazoxide for 10 months in a dose of 10 mg/kg/d with a 5% maltose dextrin diet, under correct glycaemic monitoring.
Diazoxide Causality Assessment of a Pericardial Effusion in a Child with Kabuki Syndrome
Prior to this, diazoxide choline received orphan designation for the treatment of PWS in the US and in the E.U.
Soleno Therapeutics Touts Positive Outcome from Planned Data Safety Monitoring Board Review of Phase III DESTINY PWS Clinical Trial of DCCR in Prader-Willi Syndrome
She had a diagnosis of transient hyperinsulinemic hypoglycemia (serum insulin 20 IU/mL, glucose 34 mg/dL) during the neonatal and early infancy period and had been on diazoxide therapy.
Pediatric Bilateral Pheochromocytoma and Experience of Laparoscopic Cortical Sparing Adrenalectomy
Soleno Therapeutics was granted Fast Track designation by the FDA to Diazoxide Choline Controlled-Release (DCCR) for the treatment of Prader-Willi Syndrome (PWS).
Roche's Tecentriq Gains Third Breakthrough Designation: Athenex's Phase III studies of KX-AK-003 and KX-AK-004 achieve their primary endpoint
Soleno Therapeutics Inc (NASDAQ: SLNO) has launched its Phase III clinical trial of Diazoxide Choline Controlled-Release (DCCR) for the treatment of Prader-Willi Syndrome (PWS), the biopharmaceutical company revealed on Monday.
Soleno starts Phase III trial of DCCR in Prader-Willi Syndrome
Riazuddin, "Diazoxide preconditioning of endothelial progenitor cells from streptozotocin-induced type 1 diabetic rats improves their ability to repair diabetic cardiomyopathy," Molecular and Cellular Biochemistry, vol.
Recent Progress in Stem Cell Modification for Cardiac Regeneration
Medical management of GDH-HI disease relies on protein restriction and/or treatment with diazoxide. More than 100 patients with GDH-HI have been described [4].
Clinical and Molecular Spectrum of Glutamate Dehydrogenase Gene Defects in 26 Chinese Congenital Hyperinsulinemia Patients
Fifty-five (70%) of the patients used preoperative medication: 47 (59%) used diazoxide, 10 (13%) used a somatostatin analogue, and 4 (5%) used both compounds.
Characteristics and Outcomes of 79 Patients with an Insulinoma: A Nationwide Retrospective Study in Finland

Dictionary browser ?
Full browser ?